Director/PDMR Shareholding

RNS Number : 9157Z

Dechra Pharmaceuticals PLC

23 September 2020

 

23 September 2020

Dechra^® Pharmaceuticals PLC

(Dechra or the Company)

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Dechra Pharmaceuticals PLC announces that on 21 September 2020,   the following PDMRs exercised nil cost options over ordinary shares of 1p each in the Company. The options were granted to them on 2 March 2018 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP). The exercise of the options was subject to the achievement of performance conditions which were satisfied to the extent that the options vested at 73.7%. Ian Page and Tony Griffin sold sufficient shares (acquired pursuant to the exercise) in order to fund the resulting tax liability. In accordance with the Company's Directors' Remuneration Policy, the remaining shares must be retained for a period of two years from the date of vesting. 

Name	Capacity	Options Exercised	Shares Sold	Sale Price per share	Total beneficial shareholding following this announcement	Percentage of issued share capital
Ian Page	Director	29,409	13,864	£31.48220	638,919	0.591%
Tony Griffin	Director	8,916	4,472	£31.48220	75,050	0.069%

In connection with the exercise, Ian Page's tax qualifying option over 1,197 shares granted on 2 March 2018 at an exercise price of £25.06 lapsed. 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Forms

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Ian Page
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Exercise of 29,409 options under the Company's Long Term Incentive Plan
c)	Price(s) and volumes(s)	Price(s) £Nil Cost	Volume(s) 29,409
d)	Aggregated information -  Aggregate volume -  Price	N/A
e)	Date of the transaction	2020.09.21
f)	Place of the transaction	Outside a trading venue

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Ian Page
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Partial sale of shares obtained under the Company's Long Term Incentive Plan to satisfy tax liability
c)	Price(s) and volumes(s)	Price(s) £ 31.4822	Volume(s) 13,864
d)	Aggregated information -  Aggregate volume -  Price -  Total	13,864 £ 31.4822 £436,469.22
e)	Date of the transaction	2020.09.22
f)	Place of the transaction	London Stock Exchange

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Tony Griffin
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Exercise of 8,916 options under the Company's Long Term Incentive Plan
c)	Price(s) and volumes(s)	Price(s) £nil	Volume(s) 8,916
d)	Aggregated information -  Aggregate volume -  Price	N/A
e)	Date of the transaction	2020.09.21
f)	Place of the transaction	Outside a trading venue

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Tony Griffin
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Sale of shares obtained under the Company's Long Term Incentive Plan .
c)	Price(s) and volumes(s)	Price(s) £31.4822	Volume(s) 4,472
d)	Aggregated information -  Aggregate volume -  Price -  Total	4,472 £ 31.4822 £140,788.40
e)	Date of the transaction	2020.09.22
f)	Place of the transaction	London Stock Exchange

For further information, please contact:

Melanie Hall, Company Secretary 

Telephone number: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHKKNBDQBKDFCB